EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prescription Medication Use During Pregnancy and Postpartum in Sweden 2007 to 2022

Essi Whaites Heinonen iD, Awad I Smew iD, Silvia Segovia Chacón iD, Ulrika Nörby iD, Olof Stephansson iD, Anne K Örtqvist iD, Cathrine Axfors iD, Pär Karlsson iD, Carolyn E Cesta iD

Pharmacoepidemiology and Drug Safety · 2026-09 · 35 (9)

DOI: 10.1002/pds.70473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 09.09.2026. Verfasst von Essi Whaites Heinonen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmacoepidemiology, Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Postpartum Period, Prescription Drugs, Drug Utilization, Drug Prescriptions. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Medication use during pregnancy has increased worldwide. The aim was to investigate patterns of prescription medication use during pregnancy and postpartum in Sweden 2007–2022.

Methods

We conducted a population‐based drug utilization study with linked data from the Swedish Medical Birth and Prescribed Drug Registers. From 90 days before pregnancy to 90 days after delivery, all dispensed prescriptions for each full‐level ATC code were identified. The proportion of women, by year and age, with ≥ 1 dispensed medication was calculated, as well as the number of different medications and dispensed prescriptions of structural teratogens and specific medication groups.

Results

Overall, 1 065 593 (60.5%) women were dispensed ≥ 1 medication during pregnancy and 900 536 (51.1%) within 3 months postpartum. The proportion of women with ≥ 1 dispensed prescription in the postpartum period was stable but increased during pregnancy from 57.1% in 2007 to 67.5% in 2022, with the largest increase in women ≥ 40 years. The proportion using ≥ 5 different medications increased, while the proportion with a recognized or suspected structural teratogen in the first trimester remained low (< 1%). There was a notable decrease in the use of antibiotics and prescribed analgesics, and an increase in antiemetics, psychotropics, acetylsalicylic acid, anticoagulants, antihypertensives, and antidiabetics.

Conclusion

Medication use during pregnancy in Sweden increased from 2007 to 2022, particularly among women ≥ 40 years, while postpartum use remained stable. Shifts in the use of specific medication groups highlight evolving maternal characteristics and clinical practice, as well as the importance of continuous surveillance and investigation of medication safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postpartum PeriodPrescription DrugsDrug UtilizationDrug PrescriptionsPractice Patterns, Physicians'HumansFemaleSwedenPregnancyAdultYoung AdultRegistries

Stichwörter der Autor:innen

drug utilizationmaternal agemedicationpharmacoepidemiologypostpartumpregnancy

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • Centre for Pharmacoepidemiology, Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Neonatology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
  • Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden.
  • Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Women's Health, Division of Obstetrics, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Essi Whaites Heinonen, Awad I Smew, Silvia Segovia Chacón, Ulrika Nörby, Olof Stephansson, Anne K Örtqvist, Cathrine Axfors, Pär Karlsson, Carolyn E Cesta

Zitieren

APA

Heinonen, E. W., Smew, A. I., Chacón, S. S., Nörby, U., Stephansson, O., Örtqvist, A. K., Axfors, C., Karlsson, P., & Cesta, C. E. (2026). Prescription Medication Use During Pregnancy and Postpartum in Sweden 2007 to 2022. Pharmacoepidemiology and Drug Safety, 35(9). https://doi.org/10.1002/pds.70473

Vancouver

Heinonen EW, Smew AI, Chacón SS, Nörby U, Stephansson O, Örtqvist AK, et al. Prescription Medication Use During Pregnancy and Postpartum in Sweden 2007 to 2022. Pharmacoepidemiology and Drug Safety. 2026;35(9). doi:10.1002/pds.70473

BibTeX
@article{Heinonen2026,
  author = {Heinonen, Essi Whaites and Smew, Awad I and Chacón, Silvia Segovia and Nörby, Ulrika and Stephansson, Olof and Örtqvist, Anne K and Axfors, Cathrine and Karlsson, Pär and Cesta, Carolyn E},
  title = {Prescription Medication Use During Pregnancy and Postpartum in Sweden 2007 to 2022},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {9},
  doi = {10.1002/pds.70473}
}
Kostenlos starten →